Co-founder, Chairman, & CEO at Cabaletta Bio (CABA:Nasdaq)
Villanova, Pennsylvania
HBMS
Chairman & CEO
2014 to Present
ControlRad Systems
Chairman of the Board
2012 to Present
GBF, LLC
Managing Partner
2011 to Present
The Wharton School
Adjunct Professor
2011 to Present
Greater Philadelphia Area
Israel Biotech Fund
Fund Advisor
2015 to Present
University of Pennsylvania
Board of Overseers - School of Arts and Sciences
2008 to Present
Greater Philadelphia Area
Main Line Health
Board of Governors
2014 to Present
Bioadvance Greenhouse Fund
Board of Directors
2007 to Present
Alliance for Regenerative Medicine
Board of Directors
2009 to 2014
Pennsylvania Bio
Director and Past Chairman of the Board
2007 to 2014
Biotechnology Industry Organization
Board of Directors
2010 to 2011
Tengion
President, CEO, and Director
2004 to 2011
Merck
Various Commercial Leadership Positions
1995 to 2003
Coupco
Founder and CEO
1984 to 2002
Mount Sinai Medical Center
Cardiology Fellow / Medicine Resident
1989 to 1995
What company does Steven MD work for?
Steven MD works for HBMS
What is Steven MD's role at HBMS?
Steven MD is Chairman & CEO
What industry does Steven MD work in?
Steven MD works in the Biotechnology industry.
Who are Steven MD's colleagues?
Steven MD's colleagues are Yan Li, David FACR, Anup Marda, Gwendolyn PhD, and Samik Basu
📖 Summary
Serial entrepreneur, investor, and experienced healthcare leader with broad experience including: global pharmaceuticals, biotechnology and devices across commercial, manufacturing, regulatory, clinical and research domains. Key achievements include successful commercial launches in primary care and specialty pharmaceuticals, organizational restructurings, company formation, growth, and leadership of a NASDAQ listed biotech company. Nationally recognized with the Ernst & Young Entrepreneur of the Year® award for emerging companies in 2008. Experience: • Chairman and founding CEO of HBMS • Chairman of ControlRad Systems, advancing products to dramatically reduce the dose of medical radiation needed to perform diagnostic and interventional procedures • CEO and President of Tengion, advancing novel regenerative medicine products to late stage clinical trials; raised over $225MM from top tier strategic, public, and venture investors • Senior commercial operating and strategic leader at Merck with a record of consistently delivering operating results and effectively integrating commercial priorities with research and manufacturing across the entire Merck product portfolio and research pipeline • Founder and President of Coupco, developing the first paperless discount couponing system and licensing seminal intellectual property to leading internet marketing companiesChairman & CEO @ From 2014 to Present (1 year) Chairman of the Board @ Developing products to dramatically reduce the dose of medical radiation needed to perform diagnostic and interventional procedures. From 2012 to Present (3 years) Managing Partner @ Providing advice to healthcare companies, investors, and leading academic scientists to maximize the value of breakthrough advances. Investing in potentially transformative healthcare advances. From 2011 to Present (4 years) Adjunct Professor @ Leading the capstone course for the Vagelos Life Sciences and Mangement Program (LSM). Beyond gaining experience in analyzing a new technology from both scientific and business perspectives, the team-orientation of the capstone course is designed to teach students about the qualities of leadership that make for success in the real world. LSM is a specialized, coordinated dual degree program. The curriculum weaves three elements—the business education of Wharton; life science and liberal arts classes from the College; as well as distinctive LSM courses—into a unified, interdisciplinary course of study, leading to the completion of two degrees in four years. From 2011 to Present (4 years) Greater Philadelphia AreaFund Advisor @ From 2015 to Present (less than a year) Board of Overseers - School of Arts and Sciences @ From 2008 to Present (7 years) Greater Philadelphia AreaBoard of Governors @ Founded in 1985, Main Line Health (MLH) is a not-for-profit health system serving portions of Philadelphia and its western suburbs. At its core are four of the region’s respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital, and Riddle Hospital—as well as one of the nation’s premier facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital. From 2014 to Present (1 year) Board of Directors @ BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its $20 million Greenhouse Fund. We invest in therapeutics, devices, diagnostics and platform technologies focused on human health. From 2007 to Present (8 years) Board of Directors @ From 2009 to 2014 (5 years) Director and Past Chairman of the Board @ From 2007 to 2014 (7 years) Board of Directors @ From 2010 to 2011 (1 year) President, CEO, and Director @ From 2004 to 2011 (7 years) Various Commercial Leadership Positions @ From 1995 to 2003 (8 years) Founder and CEO @ From 1984 to 2002 (18 years) Cardiology Fellow / Medicine Resident @ From 1989 to 1995 (6 years) Steven MD is skilled in: Pharmaceutical Industry, Clinical Trials, Lifesciences, Biotechnology, Start-ups, Technology Transfer, FDA, Strategic Partnerships, Commercialization, Strategy, Healthcare, Entrepreneurship, Venture Capital, Clinical Research, Leadership
Introversion (I), Sensing (S), Feeling (F), Perceiving (P)
5 year(s), 4 month(s)
Unlikely
Likely
There's 73% chance that Steven MD is seeking for new opportunities
Issued by Wharton · May 2015
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 400K users from
76% of Fortune 500 companies
The most accurate data ever
Hire Anyone, Anywhere
with ContactOut today
Making remote or global hires? We can help.
No credit card required
Steven MD's Social Media Links
lsm.upenn.... www.contro...